Print

Print


International Research Training Group (IRTG 2150)

The Neuroscience of Modulating Aggression and Impulsivity in Psychopathology
One position for a post-doctoral fellow available

 

The International Research Training Group “The Neuroscience of Modulating Aggression and Impulsivity in Psychopathology” (IRTG 2150) invites applications for a full-time post-doctoral researcher, with the position starting immediately. Applicants should have a doctoral degree (at the time of the appointment) in one of the related disciplines (medicine, psychology, neuroscience, biology, physics, mathematics, engineering).

 

Applicants should have a strong interest and methodological expertise in a relevant area (fMRI, PET, EEG, specific analysis techniques or stimulation techniques, neuropsychology, psychopathology) or a scientific contribution in the relevant area of the neuroscience of pathological aggression and impulsivity. Applicants should demonstrate successful research experience by an excellent publication record with respect to their scientific age.

 

The post-doctoral fellow is expected to develop and conduct his/her own research within the thematic focus of the program, and be willing to assist the IRTG faculty members in organizing and conducting the training aspects of the program. Applicants must have a good working knowledge of spoken and written English. Knowledge of German is not required but advantageous. Comensuration is according to German federal regulations. Appointments within the IRTG are limited to a 2-year maximum due to DFG regulations, but applicants are strongly supported in seeking follow-up funding.

 

The IRTG 2150 is funded by the German Research Foundation (DFG), and provides an international research and training program for doctoral students in a network comprising the neuroscience research at RWTH Aachen University and the Research Center Jülich in Germany, with an intense collaboration with the University of Pennsylvania (USA). The program is situated within the framework of the Jülich-Aachen Research Alliance (JARA-BRAIN, www.jara.org/jara-brain).

 

The participating institutions are the Department of Psychiatry, Psychotherapy and Psychosomatics, the Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, the Department of Neurology, the Department of Biology, and the Institutes of Neuroscience and Medicine at the Forschungszentrum Jülich. Within this IRTG, we employ a continuum of highly translational approaches, specifically neuroimaging studies, as our major methodological focus, conducting behavioral, electrophysiological and neuroendocrinological human studies. This core concept is strengthened by also involving molecular and animal studies. Two research lines are pursued: First, we investigate major risk and influencing factors. We focus on patients with mental disorders as well as on healthy individuals and investigate the effects of these influencing factors on neural networks and neurotransmitters. Second, we aim to identify ways to modulate and alter impulsivity and aggressive behavior by neuromodulatory (e.g. tDCS, neurofeedback, TMS), psychosocial (e.g. emotion regulation), pharmacological means in humans and in rodents and analyze the effects on the underlying cerebral connectivity.

 

The RWTH Aachen aims to increase the number of women in areas in which they are underrepresented, thus women are strongly encouraged to apply. For further information please see: www.rwth-aachen.de/equality

 

The RWTH Aachen aims to integrate persons with disabilities, thus such persons are strongly encouraged to apply. For further information please see: www.rwth-aachen.de/disabilities

 

Please send applications including CV, cover letter and a 1-page letter of motivation to [log in to unmask]. Informal enquiries may be made to the coordinator of the program, Prof. Dr. Ute Habel, Email: [log in to unmask]

 

 

Speakers of the program are

 

Prof. Dr. Ute Habel, Department of Psychiatry and Psychotherapy, School of Medicine, RWTH Aachen University

 

Prof. Dr. Ruben C. Gur, Department of Psychiatry, School of Medicine, University of Pennsylvania, Philadelphia